Evolving to newer technologies ….
-
Upload
joy-daugherty -
Category
Documents
-
view
27 -
download
4
description
Transcript of Evolving to newer technologies ….
![Page 1: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/1.jpg)
CME Program for Family CME Program for Family
PhysiciansPhysicians Ambulatory BP Ambulatory BP
MonitoringMonitoring
Brian Gore, MD CCFP Dip Epid.Brian Gore, MD CCFP Dip Epid.
Part IIPart IIABPMABPM
![Page 2: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/2.jpg)
Evolving to newer technologiesEvolving to newer technologies….….
![Page 3: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/3.jpg)
![Page 4: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/4.jpg)
Clinical Indications for Clinical Indications for ABPMABPM
![Page 5: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/5.jpg)
Clinical Indications for ABPMClinical Indications for ABPMT Pickering, Am J Hyperten, 1996, O’Brien, Prague ISH, June 2002T Pickering, Am J Hyperten, 1996, O’Brien, Prague ISH, June 2002
Suspected WCH or WCE w/o target Suspected WCH or WCE w/o target organ damageorgan damage
Evaluation of treatment resistant HTNEvaluation of treatment resistant HTN Hypotension symptoms on Hypotension symptoms on
antihypertensive medicationantihypertensive medication
![Page 6: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/6.jpg)
Clinical Indications Clinical Indications (cont)(cont)T Pickering, Am J Hyperten, 1996, O’Brien, Prague ISH, June 2002T Pickering, Am J Hyperten, 1996, O’Brien, Prague ISH, June 2002
Intermittent symptoms possibly related Intermittent symptoms possibly related to blood pressure (postural, to blood pressure (postural, postprandial)postprandial)
Nocturnal hypertension (sleep apnea, Nocturnal hypertension (sleep apnea, diabetics)diabetics)
Autonomic failure: diabeticsAutonomic failure: diabetics
![Page 7: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/7.jpg)
What to assess in an ABPMWhat to assess in an ABPM EvaluationEvaluation
ABPM readings: quality, #, pattern. ABPM readings: quality, #, pattern. Periods: total 24 hour, awake, asleep.Periods: total 24 hour, awake, asleep. Dipper status: Y,N, Excessive, ReverseDipper status: Y,N, Excessive, Reverse 24-hour pulse pressure.24-hour pulse pressure. White coat HTN or effect.White coat HTN or effect. Heart rate and rate-pressure productHeart rate and rate-pressure product..
![Page 8: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/8.jpg)
Summary Guide to Interpret ABPM Analyzing the data:Analyzing the data:
Minimum number acceptable:
14 readings day-time
7 readings night-time
O’Brien, BMJ: 2001
![Page 9: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/9.jpg)
Summary Guide to Interpret ABPM Results Summary Guide to Interpret ABPM Results
Analyzing the data 1:Analyzing the data 1:
ABPM profiles:
- - normal day and night periods - white coat syndrome (includes WCH + WCE) - borderline hypertension - nocturnal hypertension
![Page 10: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/10.jpg)
Summary Guide to Interpret ABPM Results Summary Guide to Interpret ABPM Results
Analyzing the data 2:Analyzing the data 2:
ABPM profiles:
- systolic and diastolic hypertension + dipper - systolic and diastolic hypertension + non-dipper - isolated systolic hypertension - isolated diastolic hypertension - excessive BP variability
![Page 11: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/11.jpg)
What are normal ABPM limitsWhat are normal ABPM limits
Are office BP readings comparable Are office BP readings comparable
to ABPM values ?to ABPM values ?
![Page 12: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/12.jpg)
Recommended standards for normal and abnormal pressures during ABPM.
These pressures are only a guide, and lower pressures may be abnormal in patients whose total risk factor profile is high and in whom there is concomitant disease.
Normal Abnormal
Day 135/85 >140/90
Night 120/70 >125/75
24 hour 130/80 >135/85
![Page 13: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/13.jpg)
O p era tio n a l A p p ro a ch fo r C V R isk S ra tif ica tio nV e rd e c c h ia , V . J H yp e rte ns io n 2 0 0 0 ; 3 5 :8 4 4 -8 5 1
LO W R I SK
Day- tim e ABP < 135/ 85O ptim al < 130/ 80
W hite Coat Hypertension
INTERMEDIATE RISK
Dipper (> 10% )N orm al 24 h PP
< 53 m m H g
HIGH RISK
N ondipperSBP Day to n ight reduction < 10%
HIGH RISK
I ncreased 24 hr PP> 53 m m H g
Am bulatory Hypertension
Untreated OHT
![Page 14: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/14.jpg)
ABPM PatternsABPM Patterns
O’Brien, BMJ, April, 2000O’Brien, BMJ, April, 2000
B. Gore, personal database, 2003B. Gore, personal database, 2003
![Page 15: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/15.jpg)
Normal 24 hour ABPMNormal 24 hour ABPM
![Page 16: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/16.jpg)
White Coat HypertensionWhite Coat Hypertension
![Page 17: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/17.jpg)
White coat hypertensionWhite coat hypertension
![Page 18: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/18.jpg)
Prevalence of White Coat Prevalence of White Coat HypertensionHypertension
Ranges from 10-30% of hypertensive Ranges from 10-30% of hypertensive population based on review of population based on review of
clinical trialsclinical trials
![Page 19: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/19.jpg)
Implications of WCEImplications of WCE
Overestimation of OBP Overestimation of OBP Potential for overtreatmentPotential for overtreatment Nonresponse to RxNonresponse to Rx Potential Rx adverse Potential Rx adverse
effectseffects
![Page 20: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/20.jpg)
Stage 1 hypertensive dipperStage 1 hypertensive dipper
![Page 21: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/21.jpg)
Stage 2 hypertensive dipperStage 2 hypertensive dipper
![Page 22: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/22.jpg)
Hypertensive Dipper (>SHTN)Hypertensive Dipper (>SHTN)
![Page 23: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/23.jpg)
Isolated Systolic HTNIsolated Systolic HTN
![Page 24: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/24.jpg)
Hypertensive Non-DipperHypertensive Non-Dipper
![Page 25: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/25.jpg)
Stage 3 HTN Non-DipperStage 3 HTN Non-Dipper
![Page 26: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/26.jpg)
Dippers and Non-DippersDippers and Non-Dippers
Dipper:Dipper: Day/Night >10/5 Day/Night >10/5 mmHgmmHg
Non-Dipper: Day/Night <10/5 mmHgNon-Dipper: Day/Night <10/5 mmHg
Dipper: Stroke 3%Dipper: Stroke 3% Non-Dipper: Stroke 23%Non-Dipper: Stroke 23%
O’Brien et al, Lancet 1988O’Brien et al, Lancet 1988
![Page 27: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/27.jpg)
ABPM IntrigueABPM Intrigue
![Page 28: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/28.jpg)
Normal 24 hr ABP with morning surgeNormal 24 hr ABP with morning surge
![Page 29: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/29.jpg)
CV Events that are Coincident with CV Events that are Coincident with Morning Blood Pressure ‘Surge’Morning Blood Pressure ‘Surge’
Myocardial ischemiaMyocardial ischemia
Myocardial infarctionMyocardial infarction
Sudden cardiac deathSudden cardiac death
StrokeStroke
ThromboticThrombotic HemorrhagicHemorrhagic
Adapted from: Muller, et al. 1985; Rocco, et al. 1987; Marler, et al. 1989; Willich, et al. 1992.
![Page 30: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/30.jpg)
Case: Case: Gertrude H is a 77 year-old Gertrude H is a 77 year-old femalefemale
Past History:Past History:
Diabetes type 2 for 5 years, Diabetes type 2 for 5 years, HTN, hyperlipidemia.HTN, hyperlipidemia.
OBP: 160/102OBP: 160/102
FU OBP: 166/98 (2 weeks)FU OBP: 166/98 (2 weeks)
Physical exam: Physical exam: Unremarkable. Unremarkable.
BMI: 30.BMI: 30.
Meds: Ramipril 10, HCTZ Meds: Ramipril 10, HCTZ 12.5 mg, Metformin 500 tid, 12.5 mg, Metformin 500 tid, Lipitor 20 qhs.Lipitor 20 qhs.
Significant lab:Significant lab:
CV Risk Ratio: 5.62CV Risk Ratio: 5.62
MAU 0.06 mcg/mlMAU 0.06 mcg/ml
HbA1c: .085HbA1c: .085
24-hr ABPM results:24-hr ABPM results:
24 hour abnormal ABP with 24 hour abnormal ABP with marked nocturnal marked nocturnal hypertension: commonly hypertension: commonly found in patients with found in patients with diabetes and loss of diabetes and loss of glycemic control or in glycemic control or in patients with sleep apnea.patients with sleep apnea.
![Page 31: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/31.jpg)
S+D HTN with Nocturnal HypertensionS+D HTN with Nocturnal Hypertension
![Page 32: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/32.jpg)
Inherent Variability of BP
![Page 33: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/33.jpg)
Blood Pressure Variability and Target Organ Damage: A Longitudinal Analysis
Adapted from: Frattola, et al. 1993.
p<0.01150
120
140
130
110
100
90
LVMI (g/m2)
< 95 95–108 109–120 >120
Initial 24-hour MAP (mm Hg)
n=73
Variability <group average
Variability >group average
10 8 11 8 11 9 8 8
![Page 34: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/34.jpg)
OvertreatmentOvertreatment
![Page 35: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/35.jpg)
Autonomic Dysregulation:Autonomic Dysregulation:
Typical patient characteristics:Typical patient characteristics:
65 year old female with:65 year old female with:
TOD/CCVD: CAD, LVH, CABG, TOD/CCVD: CAD, LVH, CABG, CVA, Remote MI.CVA, Remote MI.
CO-MORBIDITY: DIABETES. CO-MORBIDITY: DIABETES.
CV-RF: AGE, PM, SMOKER, CV-RF: AGE, PM, SMOKER, HYPERLIPIDEMIAHYPERLIPIDEMIA
OBPOBP: : 170-180/90170-180/90
Physical examPhysical exam: Carotid bruits, : Carotid bruits, Reduced PP’s, trophic leg changes, Reduced PP’s, trophic leg changes, Mild weakness RA. Mild weakness RA.
BMI: 29.BMI: 29.
MedsMeds: : Metroprolol 100 mg bid, Metroprolol 100 mg bid, Cozaar 100 mg qam,Cozaar 100 mg qam, Metformin Metformin 500 tid, Lipitor 20 qhs, ASA 80 mg 500 tid, Lipitor 20 qhs, ASA 80 mg QD.QD.
Lab Investigations:Lab Investigations:
TC-6.52, HDL-1.05, LDL-5.1TC-6.52, HDL-1.05, LDL-5.1
TG: 3.2, CV Risk Ratio:TG: 3.2, CV Risk Ratio:6.216.21
Proteinuria >3gm/l. HgB A1C: Proteinuria >3gm/l. HgB A1C: 0.078.0.078.
EKG: LVH, Remote inferior MI.EKG: LVH, Remote inferior MI.
Referred to evaluate 24 hour Referred to evaluate 24 hour control in view of persistently control in view of persistently high OBPhigh OBP
The Dilemma: BP management in The Dilemma: BP management in light of ABPM resultslight of ABPM results..
![Page 36: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/36.jpg)
Autonomic DysfunctionAutonomic Dysfunction
![Page 37: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/37.jpg)
Other ABP Illustrations:Other ABP Illustrations:“Trouble Coming”“Trouble Coming”
![Page 38: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/38.jpg)
Stroke Range HypertensionStroke Range Hypertension
![Page 39: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/39.jpg)
Isolated SHTN and high risk 24-hr pulse Isolated SHTN and high risk 24-hr pulse pressurepressure
![Page 40: Evolving to newer technologies ….](https://reader030.fdocuments.in/reader030/viewer/2022032414/568133e4550346895d9ad52a/html5/thumbnails/40.jpg)
Total period: 20 hour 44 min 4/3/2003 10:26 - 4/4/2003 10:26 (51 data)
SBP DBP MAP PP HR Double prod.
Mean 162 68 99 94 mmHg 56 /min 9165 Max 214 95 135 127 mmHg 67 /min 13054 Min 132 55 82 73 mmHg 46 /min 6480
SD 20 9 12 14 mmHg 6 /min 1838 DI 13 11 12 % PTE 98 8 66 % Load 781 5 127 mmHg*h/24h